To explore an epigenetic mechanism driving the differential expression of PLKs in lung cancer, we investigated the promoter methylation level of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma. This evidence concerns the gene PLK1 and lung carcinoma.